Donna Griebel

980 total citations
20 papers, 686 citations indexed

About

Donna Griebel is a scholar working on Surgery, Gastroenterology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Donna Griebel has authored 20 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Gastroenterology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Donna Griebel's work include Pharmaceutical studies and practices (5 papers), Inflammatory Bowel Disease (4 papers) and Microscopic Colitis (3 papers). Donna Griebel is often cited by papers focused on Pharmaceutical studies and practices (5 papers), Inflammatory Bowel Disease (4 papers) and Microscopic Colitis (3 papers). Donna Griebel collaborates with scholars based in United States, Japan and Canada. Donna Griebel's co-authors include Richard Pazdur, Grant A. Williams, Amna Ibrahim, Martin H. Cohen, Jogarao Gobburu, Steven Hirschfeld, Mark D. Rothmann, Atiqur Rahman, Gabriel J. Robbie and Gang Chen and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and The American Journal of Gastroenterology.

In The Last Decade

Donna Griebel

20 papers receiving 660 citations

Peers

Donna Griebel
Corey Pelletier United States
Kazuhiko Fujii Japan
Gerardo A. Vitiello United States
Thomas Cerny Switzerland
Kyoji Ogoshi Japan
Christine Darby United Kingdom
Nynke Zwart Netherlands
Hun Mo Ryoo South Korea
Fikri İçlı Türkiye
Monica Di Battista Italy
Corey Pelletier United States
Donna Griebel
Citations per year, relative to Donna Griebel Donna Griebel (= 1×) peers Corey Pelletier

Countries citing papers authored by Donna Griebel

Since Specialization
Citations

This map shows the geographic impact of Donna Griebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Griebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Griebel more than expected).

Fields of papers citing papers by Donna Griebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Griebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Griebel. The network helps show where Donna Griebel may publish in the future.

Co-authorship network of co-authors of Donna Griebel

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Griebel. A scholar is included among the top collaborators of Donna Griebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Griebel. Donna Griebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Momper, Jeremiah D., Kevin Krudys, Donna Griebel, et al.. (2020). Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy‐Induced Nausea and Vomiting. The Journal of Clinical Pharmacology. 60(6). 775–784. 4 indexed citations
2.
Leffler, Daniel A., Sonia S. Kupfer, Benjamin Lebwohl, et al.. (2016). Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop. Gastroenterology. 151(3). 407–411. 20 indexed citations
3.
Earp, Justin, Nitin Mehrotra, Donna Griebel, et al.. (2016). Esomeprazole FDA Approval in Children With GERD. Journal of Pediatric Gastroenterology and Nutrition. 65(3). 272–277. 11 indexed citations
4.
Wang, Jian, Nitin Mehrotra, In‐Sook Kim, et al.. (2016). Exposure‐Response of Palonosetron for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Pediatric Patients. Journal of Pediatric Gastroenterology and Nutrition. 63(4). 412–416. 5 indexed citations
5.
Sun, Haihao, Elektra J. Papadopoulos, Jeffrey S. Hyams, et al.. (2015). Well‐Defined and Reliable Clinical Outcome Assessments for Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 60(6). 729–736. 11 indexed citations
6.
Sun, Haihao, Richard Veselý, Robert M. Nelson, et al.. (2014). Steps Toward Harmonization for Clinical Development of Medicines in Pediatric Ulcerative Colitis—A Global Scientific Discussion, Part 2. Journal of Pediatric Gastroenterology and Nutrition. 58(6). 684–688. 11 indexed citations
7.
Sun, Haihao, Richard Veselý, Jan Taminiau, et al.. (2014). Steps Toward Harmonization for Clinical Development of Medicines in Pediatric Ulcerative Colitis—A Global Scientific Discussion, Part 1. Journal of Pediatric Gastroenterology and Nutrition. 58(6). 679–683. 7 indexed citations
8.
Gottlieb, Klaus, et al.. (2011). Modernizing clinical trial design: Could C-Reactive Protein (CRP) serve as an enrichment biomarker in Crohnʼs disease trials?. Inflammatory Bowel Diseases. 17. S23–S24. 1 indexed citations
9.
Korvick, Joyce A., et al.. (2011). Proton Pump Inhibitor Use in Infants. Journal of Pediatric Gastroenterology and Nutrition. 54(1). 8–14. 74 indexed citations
10.
Dickson, Patricia, Anne Pariser, Stephen C. Groft, et al.. (2010). Research challenges in central nervous system manifestations of inborn errors of metabolism. Molecular Genetics and Metabolism. 102(3). 326–338. 18 indexed citations
11.
Trentacosti, Ann Marie, Ruyi He, Laurie B. Burke, Donna Griebel, & Dianne L. Kennedy. (2010). Evolution of Clinical Trials for Irritable Bowel Syndrome: Issues in End Points and Study Design. The American Journal of Gastroenterology. 105(4). 731–735. 35 indexed citations
12.
Umar, Asad, Ellen Richmond, & Donna Griebel. (2007). Colorectal cancer prevention: Diet, drugs, or nothing. Current Colorectal Cancer Reports. 3(1). 16–23. 2 indexed citations
13.
Booth, Brian, Atiqur Rahman, Ramzi Dagher, et al.. (2006). Population Pharmacokinetic–Based Dosing of Intravenous Busulfan in Pediatric Patients. The Journal of Clinical Pharmacology. 47(1). 101–111. 74 indexed citations
14.
Lutz, Thomas A., Rocío López, Carol A. Burke, et al.. (2006). Is Hearing Loss an Extracolonic Manifestation of FAP?. The American Journal of Gastroenterology. 101. S554–S554. 2 indexed citations
15.
Sridhara, Rajeshwari, Gang Chen, Y. H. George, & Donna Griebel. (2004). Evaluation of Health-Related Quality-of-Life Measures in Oncology Drug Product Applications: Issues and Concerns. Journal of Biopharmaceutical Statistics. 14(1). 23–30. 6 indexed citations
16.
Ibrahim, Amna, Steven Hirschfeld, Martin H. Cohen, et al.. (2004). FDA Drug Approval Summaries: Oxaliplatin. The Oncologist. 9(1). 8–12. 140 indexed citations
17.
Booth, B, Ab Fatah Ab Rahman, Ramzi Dagher, et al.. (2003). Population pharmacokinetic (PPK) modeling and simulation‐derived dosing of intravenous busulfan (Busulfex) in pediatric patients. Clinical Pharmacology & Therapeutics. 73(2). 4 indexed citations
18.
Cohen, Martin H., Ramzi Dagher, Donna Griebel, et al.. (2002). U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic Acid. The Oncologist. 7(5). 393–400. 42 indexed citations
19.
Rothmann, Mark D., Jogarao Gobburu, Gabriel J. Robbie, et al.. (2002). Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.. PubMed. 8(10). 3034–8. 198 indexed citations
20.
Rosebraugh, Curtis J., Donna Griebel, & Donald J. DiPette. (1997). A case report of carotid artery dissection presenting as cluster headache. The American Journal of Medicine. 102(4). 418–419. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corey Pelletier Breakdown of academic impact, for papers by Kazuhiko Fujii Breakdown of academic impact, for papers by Gerardo A. Vitiello Breakdown of academic impact, for papers by Thomas Cerny Breakdown of academic impact, for papers by Kyoji Ogoshi Breakdown of academic impact, for papers by Christine Darby Breakdown of academic impact, for papers by Nynke Zwart Breakdown of academic impact, for papers by Hun Mo Ryoo Breakdown of academic impact, for papers by Fikri İçlı Breakdown of academic impact, for papers by Monica Di Battista
Rankless by CCL
2026